Sex hormone therapy and progression of cardiovascular disease in menopausal women

Rabe E. Alhurani, C. Anwar A Chahal, Ahmed T. Ahmed, Essa A. Mohamed, Virginia M Miller

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

One of the most controversial health decisions facing women is deciding upon the use of hormonal treatments for symptoms of menopause. This brief review focuses on the historical context of use of menopausal hormone treatments (MHT), summarizes results of major observational, primary and secondary prevention studies of MHT and cardiovascular (CV) outcomes, provides evidence for how sex steroids modulate CV function and identifies challenges for future research. As medicine enters an era of personalization of treatment options, additional research into sex differences in the aetiology of CV diseases will lead to better risk identification for CV disease in women and identify whether a woman might receive CV benefit from specific formulations and doses of MHT.

Original languageEnglish (US)
Pages (from-to)1065-1074
Number of pages10
JournalClinical Science
Volume130
Issue number13
DOIs
StatePublished - 2016

Fingerprint

Gonadal Steroid Hormones
Cardiovascular Diseases
Hormones
Primary Prevention
Therapeutics
Menopause
Secondary Prevention
Sex Characteristics
Steroids
Medicine
Health
Research

Keywords

  • 17 β-oestradiol
  • Atherosclerosis
  • Carotid intima-medial thickness
  • Conjugated equine oestrogens
  • Coronary artery calcification

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sex hormone therapy and progression of cardiovascular disease in menopausal women. / Alhurani, Rabe E.; Chahal, C. Anwar A; Ahmed, Ahmed T.; Mohamed, Essa A.; Miller, Virginia M.

In: Clinical Science, Vol. 130, No. 13, 2016, p. 1065-1074.

Research output: Contribution to journalReview article

Alhurani, Rabe E. ; Chahal, C. Anwar A ; Ahmed, Ahmed T. ; Mohamed, Essa A. ; Miller, Virginia M. / Sex hormone therapy and progression of cardiovascular disease in menopausal women. In: Clinical Science. 2016 ; Vol. 130, No. 13. pp. 1065-1074.
@article{838cb5a7986a4a35ba40010d6dbe61d3,
title = "Sex hormone therapy and progression of cardiovascular disease in menopausal women",
abstract = "One of the most controversial health decisions facing women is deciding upon the use of hormonal treatments for symptoms of menopause. This brief review focuses on the historical context of use of menopausal hormone treatments (MHT), summarizes results of major observational, primary and secondary prevention studies of MHT and cardiovascular (CV) outcomes, provides evidence for how sex steroids modulate CV function and identifies challenges for future research. As medicine enters an era of personalization of treatment options, additional research into sex differences in the aetiology of CV diseases will lead to better risk identification for CV disease in women and identify whether a woman might receive CV benefit from specific formulations and doses of MHT.",
keywords = "17 β-oestradiol, Atherosclerosis, Carotid intima-medial thickness, Conjugated equine oestrogens, Coronary artery calcification",
author = "Alhurani, {Rabe E.} and Chahal, {C. Anwar A} and Ahmed, {Ahmed T.} and Mohamed, {Essa A.} and Miller, {Virginia M}",
year = "2016",
doi = "10.1042/CS20160042",
language = "English (US)",
volume = "130",
pages = "1065--1074",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "13",

}

TY - JOUR

T1 - Sex hormone therapy and progression of cardiovascular disease in menopausal women

AU - Alhurani, Rabe E.

AU - Chahal, C. Anwar A

AU - Ahmed, Ahmed T.

AU - Mohamed, Essa A.

AU - Miller, Virginia M

PY - 2016

Y1 - 2016

N2 - One of the most controversial health decisions facing women is deciding upon the use of hormonal treatments for symptoms of menopause. This brief review focuses on the historical context of use of menopausal hormone treatments (MHT), summarizes results of major observational, primary and secondary prevention studies of MHT and cardiovascular (CV) outcomes, provides evidence for how sex steroids modulate CV function and identifies challenges for future research. As medicine enters an era of personalization of treatment options, additional research into sex differences in the aetiology of CV diseases will lead to better risk identification for CV disease in women and identify whether a woman might receive CV benefit from specific formulations and doses of MHT.

AB - One of the most controversial health decisions facing women is deciding upon the use of hormonal treatments for symptoms of menopause. This brief review focuses on the historical context of use of menopausal hormone treatments (MHT), summarizes results of major observational, primary and secondary prevention studies of MHT and cardiovascular (CV) outcomes, provides evidence for how sex steroids modulate CV function and identifies challenges for future research. As medicine enters an era of personalization of treatment options, additional research into sex differences in the aetiology of CV diseases will lead to better risk identification for CV disease in women and identify whether a woman might receive CV benefit from specific formulations and doses of MHT.

KW - 17 β-oestradiol

KW - Atherosclerosis

KW - Carotid intima-medial thickness

KW - Conjugated equine oestrogens

KW - Coronary artery calcification

UR - http://www.scopus.com/inward/record.url?scp=85014123247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014123247&partnerID=8YFLogxK

U2 - 10.1042/CS20160042

DO - 10.1042/CS20160042

M3 - Review article

VL - 130

SP - 1065

EP - 1074

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 13

ER -